Cypress Capital Management (Wyoming)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-440
| Closed | -$22K | – | 220 |
|
|
2019
Q2 | $22K | Hold |
440
| – | – | 0.03% | 152 |
|
|
2019
Q1 | $23K | Hold |
440
| – | – | 0.03% | 143 |
|
|
2018
Q4 | $21K | Hold |
440
| – | – | 0.04% | 176 |
|
|
2018
Q3 | $22K | Hold |
440
| – | – | 0.02% | 213 |
|
|
2018
Q2 | $22K | Hold |
440
| – | – | 0.02% | 210 |
|
|
2018
Q1 | $21K | Hold |
440
| – | – | 0.02% | 196 |
|
|
2017
Q4 | $20K | Sell |
440
-480
| -52% | -$21.8K | 0.02% | 209 |
|
|
2017
Q3 | $47K | Hold |
920
| – | – | 0.06% | 134 |
|
|
2017
Q2 | $49.6K | Buy |
920
+760
| +475% | +$41K | 0.06% | 123 |
|
|
2017
Q1 | $8.43K | Hold |
160
| – | – | 0.01% | 214 |
|
|
2016
Q4 | $7.7K | Sell |
160
-100
| -38% | -$4.81K | 0.01% | 215 |
|
|
2016
Q3 | $14K | Hold |
260
| – | – | 0.02% | 167 |
|
|
2016
Q2 | $14.1K | Sell |
260
-672
| -72% | -$36.4K | 0.02% | 156 |
|
|
2016
Q1 | $47.2K | Hold |
932
| – | – | 0.06% | 110 |
|
|
2015
Q4 | $47K | Hold |
932
| – | – | 0.06% | 118 |
|
|
2015
Q3 | $44.8K | Sell |
932
-100
| -10% | -$4.81K | 0.06% | 118 |
|
|
2015
Q2 | $53.7K | Hold |
1,032
| – | – | 0.06% | 124 |
|
|
2015
Q1 | $59.5K | Buy |
1,032
+100
| +11% | +$5.77K | 0.07% | 113 |
|
|
2014
Q4 | $49.8K | Buy |
+932
| New | +$49.8K | 0.06% | 104 |
|